Cubit Diagnostics

Cubit Diagnostics
Developing advanced molecular and immunoassay diagnostic solutions for point-of-care testing.
About
What does Cubit Diagnostics do?
Cubit Diagnostics is a startup focused on developing advanced diagnostic solutions. Their current work includes locking in the design freeze for a molecular CT/NG/TV assay, with plans for clinical studies in the first half of 2027. They are also expanding their immunoassay program, aiming to deliver actionable results at the point of care with rapid turnaround times.
What is Cubit Diagnostics's revenue?
StartupHub estimates Cubit Diagnostics's annual revenue at $199K (range $121K to $718K, 69% confidence), based on comparable companies in the sector.
What is Cubit Diagnostics's valuation?
StartupHub estimates Cubit Diagnostics's effective valuation at $10.9M (range $7.3M to $17.4M, 23% confidence), based on comparable companies in the sector.
How much funding has Cubit Diagnostics raised?
Cubit Diagnostics has raised a total of $3M in funding. The most recent round on record is SAFE.
Where is Cubit Diagnostics headquartered?
Cubit Diagnostics is headquartered in Carlsbad, California, USA.
When was Cubit Diagnostics founded?
Cubit Diagnostics was founded in 2021.
What industry does Cubit Diagnostics operate in?
Cubit Diagnostics operates in Biotechnology, Healthcare, Diagnostics, MedTech, HealthTech, Point-of-Care Testing.
How many employees does Cubit Diagnostics have?
Cubit Diagnostics has approximately 2 people on record.
Galatek develops AI-driven automation solutions for life sciences laboratories and advanced semiconductor manufacturing, focusing on precision and reproducibility.
Digital batch record software for pharmaceutical and biotech manufacturing.
Develops and commercializes treatments for central nervous system disorders, including Rett syndrome.
A deep-tech company developing nanorobotic solutions for healthcare, initially targeting dental care applications.
MatrixCode is a research focus at the Freiburg Institute for Advanced Studies (FRIAS) investigating matrisome pathology.
A company focused on privacy, Zcash accumulation, and developing cancer therapeutics.
An entrant is a company tagged Biotechnology whose domain was first registered in the window, counted from registry records in the StartupHub directory. Registry detection runs two to three weeks behind registration, so recent weeks are a floor.
No comments yet. Be the first to share your take.